Categories Uncategorized

What You Should Know About Traumatic Brain Injuries and PTSD

Brain injuries usually occur when an individual is involved in some trauma such as a fall, a blast or an accident while traumatic brain injuries occur from a sudden jolt or blow to the head. Traumatic brain injuries can be severe, moderate or mild, and are similar to concussions. Oftentimes, when individuals refer to traumatic brain injuries, they talk about the symptoms that occur following the injury, forgetting the fact that a traumatic brain injury is an actual injury.

Nearly 80% of all traumatic brain injuries in people are considered mild, with a majority of these patients fully recovering in three months without the need for special treatment. Sometimes, patients with severe or moderate traumatic brain injuries also make exceptional recoveries.

Symptoms resulting from a traumatic brain injury are referred to as post-concussion syndrome. Some individuals display all the symptoms while some only exhibit one or a few. The most common symptoms following a traumatic brain injury can be categorized as emotional, mental and physical.

Emotional symptoms include changes in personality, anxiety, anger outbursts and depression while mental symptoms include trouble putting thoughts into words, acting without thinking, poor judgement, trouble with being focused and memory issues. Physical symptoms include noise and light sensitivity, vision problems, sleep problems, fatigue, dizziness and headaches. In addition, severe cases may experience seizures and reduced response to standard medications.

Since traumatic brain injuries are caused by trauma, some patients may also develop post-traumatic stress disorder (“PTSD”). Post-traumatic stress disorder is a mental health condition that is brought about by experiencing distressing, frightening or stressful events and/or witnessing said events.

Most traumatic brain injury symptoms are similar to those of PTSD, which may make it harder for physicians to diagnose the injury. Symptoms of PTSD include severe anxiety, severe emotional distress, issues with one’s memory, negative thoughts about oneself or others, trouble sleeping, concentration problems, change in one’s personality, outbursts of anger and irritability as well as self-destructive behavior.

PTSD’s symptoms usually vary in intensity as time goes by, which makes it even more important for individuals who may have been injured to be diagnosed by a skilled clinician. Clinicians note that it is important to be evaluated because the effects of the injury could be severe, no matter how mild the injury itself was. In addition, individuals with traumatic brain injuries shouldn’t use some medications as they may do more harm than good.

With companies such as Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) actively studying compounds such as ibogaine for their efficacy in the treatment of TBI, an effective remedy could be on the horizon.

NOTE TO INVESTORS: The latest news and updates relating to Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) are available in the company’s newsroom at http://ibn.fm/MCURF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035

The global market for brain tumor treatments is experiencing significant transformation powered by advances in…

3 days ago

New Blood Test Shows Potential in Revolutionizing Early Parkinson’s Detection

A team of researchers has developed a “cost-effective” and simple blood test with the potential…

5 days ago

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible…

5 days ago

Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Transformative Partnerships Formed in Growing Pharma Sector

Strategic partnerships embrace opportunities to foster innovation, streamline processes and ultimately improve the lives of…

6 days ago

Adageis Helps Medical Providers Track and Build Revenue Through Efficient Application of Value-Based Care

Adageis provides clinics and medical groups with AI-powered tools to track financial outcomes tied to…

1 week ago

Blocking an Enzyme in Melanoma Patients Could Overcome Resistance to Immunotherapy

Approximately 65% of patients diagnosed with melanoma are unresponsive to immunotherapy. New research suggests that…

1 week ago